Septal glucagon-like peptide 1 receptor expression determines suppression of cocaine-induced behavior

Neuropsychopharmacology

Volumn 40, Issue 8, 2015, Pages 1969-1978

  Harasta, Anne E ^a   Power, John M ^a   Von Jonquieres, Georg ^a   Karl, Tim ^b,c   Drucker, Daniel J ^d   Housley, Gary D ^a   Schneider, Miriam ^e   Klugmann, Matthias ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; DOPAMINE UPTAKE INHIBITOR; GLP1R PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GENETIC COMPLEMENTATION; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; MOUSE; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; IN VITRO STUDY; INSTRUMENTAL CONDITIONING; METABOLISM; SEPTUM PELLUCIDUM; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IN VITRO TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RNA, MESSENGER; SEPTUM OF BRAIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84930820191     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.47     Document Type: Article

References (55)

1. Acuna-Goycolea C, van den Pol A (2004). Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 24: 8141-8152.
2. Alhadeff AL, Rupprecht LE, Hayes MR (2012). GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153: 647-658.
3. Bilbao A, Parkitna JR, Engblom D, Perreau-Lenz S, Sanchis-Segura C, Schneider M et al (2008). Loss of the Ca2 dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine. Proc Natl Acad Sci USA 105: 17549-17554.
4. Blume LC, Bass CE, Childers SR, Dalton GD, Roberts DC, Richardson JM et al (2013). Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and delta opioid systems. J Neurochem 124: 808-820.
5. Cearley CN, Wolfe JH (2007). A single injection of an adenoassociated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. J Neurosci 27: 9928-9940.
6. Cunningham CL, Patel P, Milner L (2006). Spatial location is critical for conditioning place preference with visual but not tactile stimuli. Behav Neurosci 120: 1115-1132.
7. Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP (2012). The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 32: 4812-4820.
8. Dossat AM, Lilly N, Kay K, Williams DL (2011). Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 31: 14453-14457.
9. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (1987). Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84: 3434-3438.
10. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X et al (2003). Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 9: 1173-1179.
11. Egecioglu E, Engel JA, Jerlhag E (2013a). The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. PLoS One 8: e77284.
12. Egecioglu E, Engel JA, Jerlhag E (2013b). The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLoS One 8: e69010.
13. Egecioglu E, Steensland P, Fredriksson I, Feltmann K, Engel JA, Jerlhag E (2013c). The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology 38: 1259-1270.
14. Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A (2012). Exendin-4 decreases amphetamine-induced locomotor activity. Physiol Behav 106: 574-578.
15. Gallagher JP, Zheng F, Hasuo H, Shinnick-Gallagher P (1995). Activities of neurons within the rat dorsolateral septal nucleus (DLSN). Prog Neurobiol 45: 373-395.
16. Göke RL, Larsen PJ, Mikkelesen JD, Sheikh SP (1995). Distribution of GLP-1 binding sites in the rat brain-evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7: 2294-2300.
17. Graham DL, Erreger K, Galli A, Stanwood GD (2013). GLP-1 analog attenuates cocaine reward. Mol Psychiatry 18: 961-962.
18. Highfield D, Clements A, Shalev U, McDonald R, Featherstone R, Stewart J et al (2000). Involvement of the medial septum in stressinduced relapse to heroin seeking in rats. Eur J Neurosci 12: 1705-1713.
19. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB et al (2006). Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51: 801-810.
20. Huston JP, Silva MA, Topic B, Muller CP (2013). What's conditioned in conditioned place preference? Trends Pharmacol Sci 34: 162-166.
21. Kalivas PW (2009). The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561-572.
22. Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S et al (2013). GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med 19: 567-575.
23. Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D et al (2006). A novel role of circadian transcription factor DBP in hippocampal plasticity. Mol Cell Neurosci 31: 303-314.
24. Klugmann M, Leichtlein CB, Symes CW, Serikawa T, Young D, During MJ (2005). Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Mol Ther 11: 745-753.
25. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A et al (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168-176.
26. Llewellyn-Smith IJ, Reimann F, Gribble FM, Trapp S (2011). Preproglucagon neurons project widely to autonomic control areas in the mouse brain. Neuroscience 180: 111-121.
27. Luo AH, Tahsili-Fahadan P, Wise RA, Lupica CR, Aston-Jones G (2011). Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area. Science 333: 353-357.
28. MacLusky NJ (2000). Neuroendocrine Function and Response to Stress in Mice with Complete Disruption of Glucagon-Like Peptide-1 Receptor Signaling. Endocrinology 141: 752-762.
29. Marsicano G, Lutz B (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11: 4213-4225.
30. Mazei-Robison MS, Koo JW, Friedman AK, Lansink CS, Robison AJ, Vinish M et al (2011). Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron 72: 977-990.
31. Merchenthaler IL, Lane M, Shughrue P (1999). Distribution of prepro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. Comp Neurol 403: 261-280.
32. Michalikova S, van Rensburg R, Chazot PL, Ennaceur A (2010). Anxiety responses in Balb/c, c57 and CD-1 mice exposed to a novel open space test. Behav Brain Res 207: 402-417.
33. Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, Olivos DR, Alhadeff AL, Pierce RC et al (2013). The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am J Physiol Endocrinol Metab 305: E1367-E1374.
34. Noda Y, Mamiya T, Furukawa H, Nabeshima T (1997). Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice. Eur J Pharmacol 324: 135-140.
35. Olds J, Milner P (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 47: 419-427.
36. Onteniente B, Geffard M, Campistron G, Calas A (1987). An ultrastructural study of GABA-immunoreactive neurons and terminals in the septum of the rat. J Neurosci 7: 48-54.
37. Power JM, Sah P (2007). Distribution of IP3-mediated calcium responses and their role in nuclear signalling in rat basolateral amygdala neurons. J Physiol 580: 835-857.
38. Prado-Alcala R, Streather A, Wise RA (1984). Brain stimulation reward and dopamine terminal fields. II. Septal and cortical projections. Brain Res 301: 209-219.
39. Pyke C, Knudsen LB (2013). The glucagon-like peptide-1 receptor-or not? Endocrinology 154: 4-8.
40. Rinaman L (2010). Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 1350: 18-34.
41. Risold PY, Swanson LW (1997a). Chemoarchitecture of the rat lateral septal nucleus. Brain Res Brain Res Rev 24: 91-113.
42. Risold PY, Swanson LW (1997b). Connections of the rat lateral septal complex. Brain Res Brain Res Rev 24: 115-195.
43. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
44. Sartor GC, Aston-Jones GS (2012). A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. J Neurosci 32: 4623-4631.
45. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL et al (1996). Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2: 1254-1258.
46. Sheehan T (2004). Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Rev 46: 71-117.
47. Shirazi RH, Dickson SL, Skibicka KP (2013). Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward. PLoS One 8: e61965.
48. Skibicka KP (2013). The central GLP-1: implications for food and drug reward. Front Neurosci 7: 181.
49. Skibicka KP, Hansson C, Alvarez-Crespo M, Friberg PA, Dickson SL (2011). Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 180: 129-137.
50. Swanson LW (1982). The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9: 321-353.
51. van Bloemendaal L, IJzerman RG, Ten Kulve JS, Barkhof F, Konrad RJ, Drent ML et al (2014). GLP-1 receptor activation modulates appetite-and reward-related brain areas in humans. Diabetes 63: 4186-4196.
52. Volkow ND, Wise RA (2005). How can drug addiction help us understand obesity? Nat Neurosci 8: 555-560.
53. von Jonquieres G, Mersmann N, Klugmann CB, Harasta AE, Lutz B, Teahan O et al (2013). Glial promoter selectivity following AAVdelivery to the immature brain. PLoS One 8: e65646.
54. Yang H, Wanner IB, Roper SD, Chaudhari N (1999). An optimized method for in situ hybridization with signal amplification that allows the detection of rare mRNAs. J Histochem Cytochem 47: 431-446.
55. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ Jr. et al (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28: 158-167.